Editas Medicine, Inc. 10-Q

Item 1A. Risk Factors. ​ Information set forth in this Quarterly Report on Form 10-Q and in the sections entitled “Summary of Risk Factors” and Part I, “Item 1A. Risk Factors” in the Annual Report, includes risks which could materially affect our business, financial condition, results of operations, or prospects. These risks, as well as other risks and uncertainties, could materially and adversely affect our business, results of operations and financial condition, which in turn could materially and adversely affect the trading price of shares of our common stock. Additional risks not currently known to us or that we currently deem to be immaterial may also harm our business. ​ ​ Item 6. Exhibits ​ Exhibit Index ​ Exhibit Number Description of Exhibit 3.1 ​ Amended and Restated By-Laws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-37687) filed with the Securities and Exchange Commission on March 14, 2023 ) 31.1* ​ Rule 13a-14(a) Certification of Principal Executive Officer 31.2* ​ Rule 13a-14(a) Certification of Principal Financial Officer 32.1+ ​ Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. §1350 101* ​ The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets (unaudited), (ii) Condensed Consolidated Statements of Operations (unaudited), (iii) Condensed Consolidated Statements of Comprehensive Loss (unaudited), (iv) Condensed Consolidated Statements of Stockholders’ Equity (unaudited), (v) Condensed Consolidated Statements of Cash Flows (unaudited) and (vi) Notes to Condensed Consolidated Financial Statements (unaudited), tagged as blocks of text and including detailed tags. 104* ​ The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL. ​ ​ * Filed herewith + The certifications furnished in Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q are not deemed 25 Table of Contents “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications are not to be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates them by reference. ​ ​ 26 Table of Contents SIGNATURES ​ Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ ​ ​ ​ ​ EDITAS MEDICINE, INC. ​ ​ ​ ​ ​ ​ Dated: May 5, 2023 By: /s/ Michelle Robertson ​ ​ Michelle Robertson ​ ​ Chief Financial Officer (Principal Financial Officer) ​ ​ ​ ​ 27